Biography / Cv

Speaker Name

Paolo MORGAGNI

Paolo Morgagni was born on 23/08/1959 in Forlì Italy, he graduated in 1985 at Bologna University, Italy and became a General Surgeon in 1990 at Bologna University, presenting a study on: Gastric surgery on patients over 80 years old.

PROFESSIONAL EXPERIENCE

1986 – 1987
Served as a medical doctor in the Italian Army.

1989 – 1994
Worked as a surgeon at G. B. Morgagni General Hospital, Forlì.

1992 –
Stage at Service des le maladies de l’Oesophage. Hopital S Marguerite Marseille 1995 – 1996: Worked as a surgeon at Bentivoglio General Hospital, Bologna.

1997 – present
Has been working in the surgical department of Forlì G. B. Morgagni-L. Pierantoni General Hospital where, since 2007, he has held the position of “High Professional Task in Gastric Cancer” and is the hospital coordinator in charge of the department’s team and oversees the multidisciplinary Oncologic Gastric Cancer Group.

2013 and 2015
Coordinator of gastric cancer treatment for the Romagna territory (Area Vasta Romagnola) and organized two congresses for the Italian Association Hospital Surgeons (ACOI), involving eight General Hospitals of the Romagna territory.

1998
Founding partner of the Italian Gastric Cancer Association (GIRCG), and since 2017, has been a coordinator for the GIRCG working commissions.

1999 – present
Member of the International Gastric Cancer Association (IGCA).

2000
Internship in gastric cancer treatment at the Tokyo National Cancer Center. 1994, 1998 and 2012: Organized three gastric cancer multidisciplinary meeting in Bertinoro (Forlì) on behalf of the GIRCG.

2007-2011
Was on the International Scientific Committee of 7th IGCA congress in San Paolo, on the 8th in Krakow, and on the 9th in Seoul.

2008 – 2011
Was a teacher at the Italian National Medicine Academy for gastric cancer treatment.

2013
Was chairman of the Scientific Committee’s 10th IGCA congres in Verona and then again on the Scientific Committee in San Paolo in 2015, Beijing in 2017, Prague’s IGCA congress in 2019, Houston IGCA congress in 2021 Yokohama IGCA 2023 and Amsterdam IGCA 2025. He is now collaborating to the Santiago 17 IGCA 2027 congres organization.

2013
Collaborated at the Italian guidelines on gastric cancer treatment on behalf of the Italian Surgical Society (SIC) and then for the Italian Group of Research for Gastric Cancer (GIRCG) guidelines, as published in 2014 on Gastric Cancer.

2018
Was President of the international congress: “New Frontiers in Gastric Cancer”, Forlì ( 32 international speakers from 13 countires).

2018
Obtained the National Scientific University Professor Suitability.

2019
Internship on Gastric Cancer Treatment at the National University Hospital of Seoul (SNUH). Invitation as speaker at the 44’ KLASS workshop

2022
Member of the IGCA European Chapter, he has actively participated at the y Congress in Geneve 2023 and Siena 2024 and now is collaborating to the Krakow 2026 congress

2022
President of the Internationale workshop: Stage IV gastric cancer: a working strategy in a foggy landscape”. (97 International speakers from 35 oncologic centres)

2022
Requested in the Scientific Commission of the Patient’s advocacy association “ Vivere senza lo stomaco si può”

2023
IGCA Council Member nomination at the Yokohama congress. 2023 Invited as speaker at the KINGCA Korean congres

2023
AUSL Area Vasta Romagna (7 General Hospital) multidisciplinary gastric cancer Treatment coordinator, published common PDTA in 2025

2024
Coordinator of a Romagna Oncologic Institute project regarding the postoperative and nutritional patient’s support : “Pollicino Project at IOR PRIME center Pievesistina (FC, Italy ).

2024
Coordinator of the IGCA Metastatic International Commission 2025 Invited as speaker at 4 Cinese International Congress in Nanjing, Hangzhou, Chengdu, Singapore

2025
President of the 2’nd International Workhop on Stage IV Gastric Cancer in Bertinoro ( 53 International and 47 italian speakers from 24 countries )

OTHER INFORMATION

His H index is 38. He is a partner of the Italian Surgical Society (SIC) and is on the Directive Board of the Italian Surgical Oncologic Society (SICO), he is a member of the Hospital Surgeon Society (ACOI). Has been requested in the scientific committee of the italian gastric cancer patient’s association “ vivere senza lo stomaco si può” with a particular attention to the hereditary gastric cancer commission and in the study of the postoperative glicemic disorders He has been or currently is a reviewer for several international scientific Journal such as the World Journal of Surgery, World Journal of gastrointestinal surgery ,World Journal of Gastroenterology ,Journal of Surgical Oncology, European Journal of Surgical Oncology, Cancers, Future Oncology and others. From 2014 to 2018, he was a tutor for medical students at Bologna University.

PUBLICATIONS AND BOOK CHAPTERS

2012 -He wrote 2 chapter of the Springler Book “Surgery in the multimodal management of gastric cancer “ G De Manzoni, F Roviello , W Siquini Editors

2013 -2 chapter of the Springler Book "What’s new in surgical oncology: a guide for surgeons in training and medical/radiation oncologists” A Valeri, C Bergamini, F Agresta, J Martellucci.

2014 -1 chapter of the Spingler book “: Gastric Cancer Principles and Practice V.E. Strong (Ed.)

2021- 5 chapter of the Springler book “Gastric Cancer: the 25 years re-evolution” G de Manzoni F Roviello Editors

INVOLVEMENT IN INTERNATIONAL CONSENSUS CONFERENCES

1) The Charter Scalgero. Consensus Internazionale su Follow up nel carcinoma Gastrico Verona 19-22 giugno 2013 .Gastric Cancer. 2016 Jan;19

2) Consensus Conferece Italian Surgical Siciety on Gastric cancer guidelines Torino Updates Surg. 2014

3) European Consensus conference on poorly choesive gastric cancer

4) European Consensus conference on surgical morbility in gastric cancer Gastric Cancer. 2018

5) Bertinoro International workshop on metastatic stage IV gastric cancer 2022

6) Bertinoro 2’ International workshop on metastatic stage IV gastric October 2025

118 PUBLICATIONS IN JOURNALS on PubMed

-Nodal abdominal spread in adenocarcinoma of cardia. Results of multicenter prospective study. Gastric Cancer 1998

-EGC follow up of 412 patients. Journal of Surgical Oncology 1999

-The role of growth patterns according to Kodama ‘s classification, and lymph node status, as important prognostic factors in EGC: analysis on 412 cases. Gastric Cancer 2000

-EGC treatment; our results. Chirurgia Generale-General Surgery 2000

-Identification of occult micrometastases in patients with EGC using anti-cytokeratin monoclonal antibodies. Oncology reports 2000

-An alternative repair technique for anastomotic leakage after total gastrectomy. J American College of Surgeon 2000

-Lymph node micrometastases in EGC : experience on 139 patients. J of Surgical Oncology 2000

-Risk factor for lymph node metastases and its prognostic significance in Early Gastric Cancer (EGC) for the Italian Research Group for Gastric Cancer Jpn J Clin Oncol 2001;31(10)

-The number of Positive Nodes is directly related to the number of excised nodes, particularly in advanced gastric cancer: result of an Italian Research Group for Gastric Cancer. 2001 Monduzzi Editore 4’ International Gastric Cancer Congress

-Influence of Histologic type on prognosis of patients undergoing curative intervention for gastric adenocarcinoma Ann Ital Chir 2001 ;72

-The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients Br J Cancer 2002 ; 87

-Different patterns of recurrence in gastric cancer depending on Lauren’s histological type: longitudinal study W J Surg 2002; 26

-Survival Benefit of extended D2 Lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study Ann Surg Oncol 2002

-Lymph node micrometastases in EGC and their impact on prognosis W J Surg 2003

-Gastric cancer in young patients with no alarm symptoms: focus on delay in diagnosis, stage of neoplasm and survival. Scand J Gastroenterol. 2003

-Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum. Gastric Cancer 2003

-Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003

-Expression of p27 and proliferative (MIB-1), mitotic (MI) and apoptotic indices in early-phase (EGF) gastric carcinoma. Results of a study by the Italian Gastric Cancer Research Group (IRGGC)] Pathologica. 2003

-Benefits of extended lymphadenectomy in patients with gastric carcinoma with metastasis to second level lymph nodes. An Italian multicenter study Chir Ital. 2003.

-Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicentric study Ann Surg 2005

-Does resection line involvement affect prognosis in early gastric cancer patients? An Italian multicentric study. World J Surg. 2006

-Perforated gastric carcinoma: a report of 10 cases and review of the literature. World J Surg Oncol. 2006

-Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study.J Surg Oncol. 2006

-The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.Ann Surg 2007

-The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008

-Resection line involvement after gastric cancer surgery: clinical outcome in nonsurgically retreated patients. WJ Surg 2008

-Subtotal gastrectomy as treatment for distal multifocal early gastric cancer. J Gastrointest Surg. 2009

-Duodenal fistula after elective gastrectomy for malignant disease : an Italian retrospective multicenter study. J Gastrointest Surg. 2010

-A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010

-Changing clinical and pathological features of gastric cancer over time. Br J Surg. 2011 Rescue endoscopy to identify site of gastric dysplasia or carcinoma found at random biopsies. Dig Liver Dis. 2011

-Validation of the new AJCC TNM staging system for gastric cancer in a large cohort of patients (n = 2,155): focus on the T category. Eur J Surg Oncol. 2011

-Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centers. Ann Surg. 2012

-Preoperative multidetector-row computed tomography scan staging for lymphatic gastric cancer spread. World J Surg Oncol. 2012 Sep

-Early gastric cancer: diagnosis, staging, and clinical impact. Evaluation of 530 patients. New elements for an updated definition and classification. Gastric Cancer. 2013

-Updates on surgical management of advanced gastric cancer: new evidence and trends. Insights from the First International Course on Upper Gastrointestinal Surgery--Varese (Italy), December 2, 2011. Ann Surg Oncol. 2013

-Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial. Gastric Cancer. 2013

-A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables. Gastric Cancer. 2013 Dec 25.

-hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. Clin Cancer Res. 2014

-Is a clear benefit in survival enough to modify patient access to the surgery service? A retrospective analysis in a cohort of gastric cancer patients. Gastric Cancer. 2014

-The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer. Updates Surg. 2014

-Gastric Stump Cancer After Distal Gastrectomy for Benign Disease: Clinicopathological Features and Surgical Outcomes Ann Surg Oncol. 2014

-Follow-up after gastrectomy for cancer: an appraisal of the italian research group for gastric cancer. Ann Surg Oncol. 2014

-VEGF-Aclinical significance in gastric cancers: Immunohistochemical analysis of a wide Italian cohort. Eur J Surg Oncol. 2014

-Gastric Stump Carcinoma after Distal Subtotal Gastrectomy for Early Gastric Cancer; Experience of 541 Patients with Long-Term Follow-Up Am J Surgery 2014

-Erratum to: Is a clear benefit in survival enough to modify patient access to the surgery service? A retrospective analysis in a cohort of gastric cancer patients. Gastric Cancer.

-Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection? Ann Surg Oncol.

-Follow-up after gastrectomy for cancer: results of an international web round table.World J Gastroenterol. 2014

-Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol. 2014

-Surgical management of duodenal stump fistula after elective gastrectomy for malignancy: an Italian retrospective multicenter study. Gastric Cancer. 2016

-Lymph node pick up by separate stations: Option or necessity. World J Gastrointest Surg. 2015

-Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference. Gastric Cancer. 2016

-External Validation of a Score Predictive of Recurrence after Radical Surgery for Non- Cardia Gastric Cancer: Results of a Follow-Up Study. J Am Coll Surg. 2015

-Multimodal treatment of gastric cancer in the west: Where are we going? World J Gastroenterol. 2015

-Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience. World J Surg. 2016

-The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer. 2017

-Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study. Eur J Surg Oncol. 2016

-Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study. Eur J Surg Oncol. 2016

-Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal- type gastric cancer. Oncotarget. 2017

-Historical assumptions of lymphadenectomy. Transl Gastroenterol Hepatol. 2016

-Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer. Ann Surg Oncol. 2017

-Complications after gastrectomy for cancer: Italian perspective. Updates Surg. 2017

-Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series. World J Gastroenterol. 2017

-Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG). Oncologist. 2018

-Laparoendoscopic rendezvous in the treatment of cholecysto-choledocholitiasis: a single series of 200 patients. Surg Endosc. 2018

-An aggressive early gastric cancer: Kodama's PenA type. Eur J Surg Oncol. 2018

-Conversion surgery for gastric cancer: A cohort study from a western center. Int J Surg. 2018

-Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study.Gastroenterol Res Pract. 2018

-International consensus on a complications list after gastrectomy for cancer. Gastric Cancer. 2018

-Resection line involvement after gastric cancer treatment: handle with care. Updates Surg. 2018

-A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits. Cancer Res. 2019

-E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer. Int J Mol Sci. 2019

-Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition. Cancers (Basel).

-Robotic vs open gastrectomy for gastric cancer: A propensity score-matched analysis on short- and long-term outcomes. Int J Med Robot. 2019

-Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study. Gastric Cancer. 2019

-International consensus on a complications list after gastrectomy for cancer. Gastric Cancer. 2019

-Retrospective analysis of gastric cancer management in a real-world setting: a single- institution experience. Tumori. 2020

-Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer. Cancers 2020

-Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study. Ann Surg. 2020

-Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial. Cancers (Basel)2020.

-Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience. Clin Nucl Med. 2020

-Early Gastric Cancer: identification of molecular markers able to distinguish submucosa- penetrating lesions with different prognosis. Gastric Cancer. 2021

-Surgical management of oncologic patient during and after the COVID-19 outbreak: practical recommendations from the Italian society of Surgical Oncology. Updates Surg. 2021.

-The effect of learning curve on perioperative outcomes of robotic gastrectomy in two western high-volume centers. Int J Med Robot. 2021

-Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer). Quant Imaging Med Surg. 2021

-Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer. Pharmaceuticals (Basel). 2021

-Early Gastric Cancer: identification of molecular markers able to distinguish submucosa- penetrating lesions with different prognosis. Gastric Cancer. 2021

-Surgical management of oncologic patient during and after the COVID-19 outbreak: practical recommendations from the Italian society of Surgical Oncology. Updates Surg. 2021

-Validating a nodal regression system for gastric cancer: An ancillary cohort study of the GASTRODOC trial. Int J Surg. 2021

-Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM). Eur Radiol. 2021

-Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group's analysis. doi: 10.1186/s12957-021-02442-9. PMID: 34819103

-Conversion Surgery in Gastric Cancer Carcinomatosis. Front Oncol. 2022 Mar 8;12:852559.

-Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study. Eur J Surg Oncol. 2022 Aug;48(8):1778-1784.

-Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST. J Clin Med. 2022 Sep 16;11(18):5439.

-Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population-on behalf of the Italian Research Group for Gastric Cancer. Italian Research Group for Gastric Cancer (GIRCG). Gastric Cancer. 2022 Nov;25(6):1105-1116.

-Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey. Italian Gastric Cancer Research Group (GIRCG), the Polispecialistic Society of Young Surgeons (SPIGC). Updates Surg. 2022 Dec;74(6):1839-1849.

-Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM). Eur Radiol. 2022 Feb;32(2):938-949.

-Frail patients dropping out of neoadjuvant treatment: what should we do? Updates Surg. 2023 Feb;75(2):403-408.

-Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy. Tumori. 2023 Feb;109(1):121-128.

-Clinical outcomes of patients with complicated post-operative course after gastrectomy for cancer: a GIRCG study using the GASTRODATA registry. Updates Surg. 2023 Feb;75(2):419-427.

-Textbook Oncological Outcome in European GASTRODATA. Ann Surg. 2023 Nov 1;278(5):823-831.

-Defining benchmarks for total and distal gastrectomy: global multicentre analysis. Br J Surg. 2024 Jan 31;111(2):znad379.

-Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer. Nutrients. 2023 Aug 17;15(16):3604.

-Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape. Gastric Cancer. 2024 Jul;27(4):672-674.

-International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022. Gastric Cancer. 2024 Jul;27(4):649-671.

-Genomic events stratifying prognosis of early gastric cancer. Gastric Cancer. 2024 Jul 19.

-Textbook Neoadjuvant Outcome-Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment. Cancers (Basel). 2024 Apr 28;16(9):1721.

-Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer. Cancers (Basel). 2023 Dec 29;16(1):170

-International External Validation of Risk Prediction Model of 90-Day Mortality after Gastrectomy for Cancer Using Machine Learning. Cancers (Basel). 2024 Jul 5;16(13):2463

-Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer - Insights from the GastroBenchmark and GASTRODATA databases. Ann Surg. 2024 Aug 5.

-A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series. Eur J Surg Oncol. 2024 Jan;50(1):107275.

-Staging laparoscopy for gastric cancer: European consensus. Br J Surg. 2025 Sep 2;112(9):znaf144.

-Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre study. Br J Surg. 2025 Mar 28;112(4):znaf043.

-Impact of prognostic nutritional index on oncological outcomes and mortality among advanced gastric cancer patients: European GASTRODATA registry analysis. Int J Cancer. 2025 Oct 15;157(8):1734-1745.

-Hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal metastasis - Joint analysis of European GASTRODATA and American national cancer database. Am J Surg. 2025 Apr;242:116235.

-Staging Laparoscopy in Gastric Cancer Patients Treated with Curative Intent: A European GASTRODATA Cohort Study. Ann Surg Oncol. 2025 Oct;32(10):7615-7626.

-The Role of Staging Laparoscopy in Stage IV Gastric Cancer Patients. Dig Surg. 2025;42(2):77-83

-Perioperative Outcomes in Open Versus Minimally Invasive Gastrectomy For Gastric Cancer: A European Multicenter Study Based on the GASTRODATA Registry. Ann Surg. 2025 Jul 24.

-Stomach cancer elective surgery morbidity and mortality at 90-Day (Hold Study): a prospective, international collaborative cohort study. Langenbecks Arch Surg. 2025 Nov 14;411(1):12.

-Enhanced Recovery Protocols in Gastrectomy for Gastric Cancer: Evaluating the Impact of Frailty. World J Surg. 2025 Nov;49(11):3217-3224

-Advancing gastric cancer treatment: A comprehensive review of hyperthermic intraperitoneal chemotherapy's role and outcomes. World J Clin Oncol. 2025 Sep 24;16(9):109034.

-PhotoNodes Protocol: A Multicenter Prospective Study for the Assessment of Proper Lymphadenectomy in Minimally Invasive Gastric Cancer Surgery Using Intraoperative Photographs. Dig Surg. 2025;42(3):146-151.